Gilead Sciences, Inc. (GILD) Get the latest Gilead Sciences, Inc (GILD) stock news and headlines to help you in your trading and investing decisions April 21, 2025--Gilead Sciences, Inc (Nasdaq: GILD) today announced
GILD Interactive Stock Chart - Yahoo Finance At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life
Gilead Sciences, Inc. (GILD) Latest Stock News Headlines - Yahoo Finance Gilead Sciences Inc (NASDAQ:GILD) is one of the 11 most profitable NASDAQ stocks to buy now On June 11, RBC Capital increased its price target for Gilead Sciences to $95 from $92, while maintaining a Sector Perform rating This adjustment is based on insights from a 2022 patient survey, which assessed perceptions of lenacapavir among […]
Gilead Sciences Stock Gains 21% YTD: Buy, Sell or Hold? GILD stock jumps 21 1% YTD as HIV dominance, lenacapavir progress, and liver drug approval offset oncology pressures However, we recommend investors remain on the sidelines at current levels
Gilead Sciences, Inc. (GILD) Find out all the key statistics for Gilead Sciences, Inc (GILD), including valuation measures, fiscal year financial statistics, trading record, share statistics and more Stock Price History